International study links Spinal Muscular Atrophy (SMA) to higher risk of fatty liver disease due to reduced SMN protein levels in liver cells.
Spinal Muscular Atrophy (SMA) patients may face a higher risk of developing fatty liver disease, according to an international study by researchers from the US, Singapore, and Scotland. The study found that SMA genetic mutation reduces SMN protein levels in liver cells, impairing fat metabolism. This suggests that SMA's impact extends beyond the nervous system, potentially affecting organs like the liver.
July 17, 2024
4 Articles